「あきらめたら そこで試合終了ですよ」という『スラムダンク』の中の安西監督が言った名言があります。この文は人々に知られています。試合と同じ、試験もそのどおりですよ。試験に準備する時間が十分ではないから、ALS-Con-201認定試験を諦めた人がたくさんいます。しかし、優秀な資料を利用すれば、短時間の準備をしても、高得点で試験に合格することができます。信じないでしょうか。PassTestの試験問題集はそのような資料ですよ。はやく試してください。
| Section | Objectives |
|---|---|
| Topic 1: Agentforce and AI Capabilities | - AI and Automation
|
| Topic 2: Agentforce Life Sciences Consulting Fundamentals | - Industry and Regulatory Context
|
| Topic 3: Customer Engagement and Field Operations | - Engagement Execution
|
| Topic 4: Data, Compliance, and Governance | - Compliance and Security
|
私たちの会社は、コンテンツだけでなくディスプレイ上でも、ALS-Con-201試験材料の設計に最新の技術を採用しています。激しく変化する世界に対応し、私たちのALS-Con-201試験資料のガイドで、あなたの長所を発揮することができます。 また、あなたも私たちのALS-Con-201試験資料を使って、個人的に重要な知識を集約し、自分の需要によって、ALS-Con-201試験のために様々な勉強方法を選ぶことができます。
質問 # 108
Choose 1 option.
A field sales rep attempts to add Immunexis to the Product Detailing section during a visit, but the product does not appear in the search results. The product record exists in Salesforce. The product must be explicitly enabled for use in visit discussions.
What should be configured in the Visit Administration tile on the Agentforce Life Sciences for Customer Engagement Admin Console?
正解：B
解説：
The correct answer is B because the product must be enabled for discussion in the visit-detailing experience. Salesforce's Life Sciences Visit Management developer documentation states that information entered in a provider visit typically includes product details, product messages, presentations, marketing items, and samples. Salesforce Trailhead also explains that Life Sciences Cloud uses product administration and product-message configuration to ensure reps only promote and discuss therapies within approved guardrails.
The scenario says the product exists in Salesforce, but it does not appear when the rep tries to add it to the Product Detailing section during a visit. That means the issue is not product creation; it is visit-discussion eligibility. The consultant should configure Product Discussion Settings in the Visit Administration area so Immunexis is available for product detailing and visit discussions.
Option A is incorrect because Territory Product Alignment Rules determine which products are aligned to territories, but the question specifically says the product must be explicitly enabled for use in visit discussions. Territory alignment alone does not guarantee the product appears in the Product Detailing search. Option C is also incorrect because Visit Record Type Mappings control record-type behavior, not whether a product can be discussed. Therefore, the correct configuration is Product Discussion Settings.
質問 # 109
Choose 1 option.
Cumulus Pharma wants a medical inquiry process configured where only a designated persona can assign and respond to medical inquiries.
Which configuration supports this compliance requirement?
正解：A
解説：
Option B is correct because Salesforce Life Sciences Medical Inquiries uses workflow actions and persona/profile-based configuration to control who can perform specific inquiry actions, such as assigning and responding. Salesforce Help states that, before setting up Medical Inquiry, admins must make sure the required user profiles, licenses, and permission sets are in place. It also describes that medical science liaisons can assign and respond to inquiries, which confirms that these actions are intended to be controlled by role or persona.
Salesforce's Life Sciences workflow documentation also identifies workflow actions and workflow stages as part of the Medical Inquiry management setup. The Medical Inquiries workflow setup includes action buttons, workflow stages, stage operations, and conditions, allowing admins to expose or restrict actions based on configured roles and workflow state.
Option A is not the best answer because the requirement is not simply to grant a broad app permission; it is to ensure that only a designated persona can perform the assign and respond actions in the controlled Medical Inquiry process. Option C is incorrect because a custom formula field only affects display logic and does not enforce the standard workflow-action permission model. Formula-based visibility also creates compliance risk because it can hide buttons without truly governing the underlying operation. Therefore, the consultant should create workflow actions and associate those actions with the appropriate profiles in the Life Sciences Admin Console.
=========
質問 # 110
Choose 1 option.
A sales operations manager has created a new Immunexis Launch Activity Plan for the year. This plan contains the correct goals and measures, but it is not visible to the San Francisco North sales team. The plan must be explicitly associated with the specific territory node to be active for those users.
Which object should the Agentforce Life Sciences Consultant populate to link the Activity Plan record to the Sales Territory?
正解：A
質問 # 111
Choose 1 option.
Cumulus Pharma implemented a custom predictive model outside of Salesforce to determine the optimal product message for Healthcare Providers (HCPs). The company wants to display these recommendations to its field sales teams within Salesforce.
Which object should an Agentforce Life Sciences Consultant load the external scores and rankings into to use the Next Best Message feature?
正解：C
解説：
The correct answer is A because Next Best Message uses product-message scoring data at the territory-account-product-message level. Salesforce's Life Sciences Cloud Developer Guide states that Next Best Message provides tailored and relevant messages for each product associated with an account. Salesforce also documents the related scoring object and describes the calculation agent used to calculate the territory account product message score based on various metrics.
The scenario says Cumulus Pharma already has a custom predictive model outside Salesforce. The goal is not to build the model inside Salesforce, but to surface the model's results to reps through the standard Next Best Message capability. Therefore, the external scores and rankings should be loaded into the object that stores ranked product-message recommendations for accounts in territories: Territory Account Product Message Score.
Option B, Visit Recommendation, is not the best answer because the requirement is specifically about product messages for HCPs, not general recommendations tied to a visit. Option C, Score Explainability Info, may support interpretation or explanation of scoring, but it is not the primary object used to load the external product-message score and ranking. To use Next Best Message with external model outputs, the consultant should load the results into Territory Account Product Message Score.
=========
質問 # 112
Choose 1 option.
An Agentforce Life Sciences Consultant is creating a new Activity Plan record. The requirement is to configure a plan that allows a strategic cycle where field sales reps act on goals defined by the home office for a specific period.
Which Usage Type must the consultant select to enable this behavior?
正解：A
解説：
The correct answer is A because the described requirement matches a Provider Plan Cycle. In Salesforce Life Sciences Cloud, Activity Plans are used to organize and guide planned field activity. Salesforce Help specifically states that when creating Activity Plans, the consultant selects Provider Plan Cycle for the Usage Type. This usage type supports a planned engagement cycle where field sales reps work against defined goals for providers during a specific period.
The wording in the scenario is important: the goals are defined by the home office and executed by field sales reps during a strategic cycle. That is not the same as a broader account planning process or a standalone territory objective. A Provider Plan Cycle is designed for provider-focused execution, where commercial strategy is translated into actionable field goals for HCP engagement.
Option B, Account Plan, is incorrect because account plans are generally used for broader key account management and strategic relationship planning, especially for major accounts or account hierarchies. It does not specifically represent the activity-plan usage type for home-office-defined provider engagement cycles. Option C, Territory Objective, is also incorrect because a territory objective represents a goal or target at the territory level, but it is not the Usage Type required when creating the Activity Plan record for provider cycle execution. Therefore, the consultant should select Provider Plan Cycle.
=========
質問 # 113
......
初めて練習を選ぶことは、ギャンブルをすることに少し似ていると思うかもしれません。 ただし、ALS-Con-201学習クイズでは、参考になる無料のデモと、バックアップとしてのプロのエリートが用意されています。 彼らは、ALS-Con-201トレーニング資料で発生したエラーについて妥協しない検閲エリートの集まりです。 そのため、彼らの正解率は信じられないほど高く、試験の受験者の98％以上が合格しました。 あなたのように成功することに熱心な熱心な受験者に試験の知識を伝えることで、彼らはそれを助けを提供する責任として扱います。 そのため、情報の特性に従って次のALS-Con-201学習ガイドを入手できる場合は、目覚ましい進歩を遂げてください。
ALS-Con-201復習内容: https://www.passtest.jp/Salesforce/ALS-Con-201-shiken.html